Co-Diagnostics, Inc. (CODX)
NASDAQ: CODX · Real-Time Price · USD
0.4928
-0.0772 (-13.54%)
Oct 29, 2025, 11:50 AM EDT - Market open
Co-Diagnostics Stock Forecast
Stock Price Forecast
The 2 analysts that cover Co-Diagnostics stock have a consensus rating of "Buy" and an average price target of $2.00, which forecasts a 305.84% increase in the stock price over the next year. The lowest target is $1.00 and the highest is $3.00.
Price Target: $2.00 (+305.84%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Co-Diagnostics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $3 | Strong Buy | Maintains | $3 | +508.77% | Oct 28, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $3 | Strong Buy | Maintains | $3 | +508.77% | Oct 16, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $10 → $3 | Strong Buy | Maintains | $10 → $3 | +508.77% | Sep 19, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $10 | Strong Buy | Maintains | $10 | +1,929.22% | Sep 17, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $10 | Strong Buy | Maintains | $10 | +1,929.22% | Aug 15, 2025 |
Financial Forecast
Revenue This Year
523.26K
from 3.92M
Decreased by -86.64%
Revenue Next Year
688.50K
from 523.26K
Increased by 31.58%
EPS This Year
-0.77
from -1.24
EPS Next Year
-0.29
from -0.77
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 853,650 | 1.4M | |||
| Avg | 523,260 | 688,500 | |||
| Low | 208,740 | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -78.2% | 171.0% | |||
| Avg | -86.6% | 31.6% | |||
| Low | -94.7% | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.76 | -0.18 | |||
| Avg | -0.77 | -0.29 | |||
| Low | -0.77 | -0.38 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.